Relapse of Type A -Lactamase-Producing Staphylococcus aureus Native Valve Endocarditis during Cefazolin Therapy: Revisiting the Issue
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Our experience with a patient with methicillin-susceptible Staphylococcus aureus aortic native valve endocarditis, who had a relapse involving fever and positive blood culture results while receiving cefazolin, led us to evaluate this organism's ability to hydrolyze cefazolin at high inocula, a previously well-documented phenomenon. Analysis of the infecting strain disclosed a high minimum inhibitory concentration of cefazolin when a large inoculum was used, as well as rapid and complete cefazolin degradation, which was associated with regrowth in a time-kill experiment. DNA sequencing of the beta-lactamase gene showed that it was identical to that of the S. aureus type A beta-lactamase, known to efficiently inactivate cefazolin. A word of caution is given regarding the use of this antibiotic for treatment of endocarditis caused by this type of S. aureus isolate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Preparation of Genomic DNA from Bacteria
Wilson, K. (2001) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb0204s56 · Cited by 2,082 · cited 1×
“Genomic DNA was extracted by the hexadecyltrimethyl ammonium bromide method, as described elsewhere [13, 14], except for the addition of lysostaphin (5 U/mL; Sigma Chemicals).”
MethodSimplified, Accurate Method for Antibiotic Assay of Clinical Specimens
Bennett, J. V., Brodie, J. L., Benner, E. J., & Kirby, W. (1966) · Applied Microbiology · doi:10.1128/aem.14.2.170-177.1966 · Cited by 955 · cited 1×
“Cefazolin concentrations were determined by agar-well diffusion bioassay using Bacillus subtilis in triplicates [11].”
MethodWilson, W. R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530210060032 · Cited by 492
Pacemaker infective endocarditis
Cacoub, P., Leprince, P., Nataf, P., Hausfater, P., Dorent, R., Wechsler, B., Bors, V., Pavie, A., Piette, J. C., & Gandjbakhch, I. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00365-8 · Cited by 314 · cited 1×
“with intracardiac leads [18], did not reveal any vegetations”
BackgroundWilson, W. R. (1995) · JAMA · doi:10.1001/jama.274.21.1706 · Cited by 288
Malathum, K., Singh, K. V., Weinstock, G. M., & Murray, B. E. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.1.211-215.1998 · Cited by 104 · cited 1×
“Genomic DNA was extracted by the hexadecyltrimethyl ammonium bromide method, as described elsewhere [13, 14], except for the addition of lysostaphin (5 U/mL; Sigma Chemicals).”
MethodSelf-citationCharacterization of four beta-lactamases produced by Staphylococcus aureus
Zygmunt, D. J., Stratton, C. W., & Kernodle, D. S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.2.440 · Cited by 102 · cited 1×
“However, we should also point out that cefazolin is relatively stable in the presence of type B and C b-lactamases [5] and that clinical cefazolin failures associated with S.”
BackgroundFailure of Cephalosporins to Prevent Staphylococcus aureus Surgical Wound Infections
Kernodle, D. S., Classen, D. C., Burke, J. F., & Kaiser, A. B. (1990) · JAMA · doi:10.1001/jama.1990.03440070049031 · Cited by 97 · cited 1×
“aureus strains producing a large amount of type A b-lactamase [10, 20].”
Background
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Clinical management of Staphylococcus aureus bacteraemia
Thwaites, G. E., Edgeworth, J. D., Gkrania-Klotsas, E., Kirby, A., Tilley, R., Török, M. E., Walker, S., Wertheim, H. F., Wilson, P., & Llewelyn, M. J. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70285-1 · Cited by 261
Update on Infective Endocarditis
Bashore, T. M., Cabell, C., & Fowler, Jr. (2006) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2005.12.001 · Cited by 227
Nannini, E. C., Stryjewski, M. E., Singh, K. V., Bourgogne, A., Rude, T. H., Corey, G. R., Fowler, V. G., & Murray, B. E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00317-09 · Cited by 160
“As previously reported (14), no increases in the cefazolin MIC at HI were observed with the Bla-negative strain ATCC 25923, while a slight increase (to 4 g/ml) was seen with the weak type A Bla producer ATCC 29213.”
BackgroundResultInfluentialSelf-citation
Metadata
- Authors
- Nannini, E. C., Singh, K. V., & Murray, B. E.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Corresponding author
- Murray, B. E.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-11-01
- Volume
- 37
- Issue
- 9
- Pages
- 1194-1198
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2137030105
- Cited by
- 103
- References
- 26
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 7 · 2019: 6 · 2018: 8 · 2017: 4 · 2016: 7 · 2015: 8 · 2014: 8 · 2013: 3 · 2012: 3
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- Staphylococcus aureus, native valve endocarditis, aortic valve endocarditis, cefazolin, beta-lactamase, antibiotic resistance, minimum inhibitory concentration, time-kill kinetics, beta-lactamase genes, antibiotic treatment failure
- MeSH terms
- Anti-Bacterial Agents, beta-Lactamases, Cefazolin, Endocarditis, Bacterial, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Recurrence, Staphylococcal Infections, Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Relapse of Type A -Lactamase-Producing Staphylococcus aureus Native Valve Endocarditis during Cefazolin Therapy: Revisiting the Issue. https://app.cochat.ai/papers/10.1086/379021
- The paper
- Nannini, E. C., Singh, K. V., & Murray, B. E. (2003). Relapse of Type A -Lactamase-Producing Staphylococcus aureus Native Valve Endocarditis during Cefazolin Therapy: Revisiting the Issue. Clinical Infectious Diseases. https://doi.org/10.1086/379021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.